Pharma To Date
Pharma Marketing
Enhance Your Patient Care with Shingrix: Insights and Opportunities
We are excited to share important information about Shingrix, a groundbreaking vaccine by GSK designed to prevent herpes zoster (shingles) and post-herpetic neuralgia (PHN). Our campaign aims to raise awareness among healthcare professionals about the severity of shingles and the prevention options available through vaccination.
Campaign Highlights
- Target Audience- Rheumatologists, Hematologists, Dermatologists, General Practitioners, and more.
- Omnichannel Approach- Engaged HCPs through HidocWeb, HidocApp, email, SMS, WhatsApp, and telecalls.
Key Metrics
- Reach- 206,204 HCPs
- Impressions- 2,451,283
- Clicks- 195,640
- Click-Through Rate (CTR)- 8%
Our survey indicated that 71.8% of medical professionals believe the Shingrix vaccine is effective in reducing shingles risk in adults aged 50 and older.
Lead Generation Process
- Lead Capture- HCPs can fill out a form for more information.
- Verification- We’ll verify details through a telecall.
- Follow-Up- Verified leads will be shared with GSK for further engagement.
In conclusion, our campaign successfully highlighted the importance of the Shingrix vaccine in preventing shingles and post-herpetic neuralgia, reaching over 206,000 healthcare professionals through an effective omnichannel strategy. The positive feedback from our survey indicates strong confidence in the vaccine's efficacy among medical practitioners. By streamlining the lead generation process, we are committed to fostering further engagement with GSK, ultimately improving patient outcomes through increased vaccination awareness and access.
Click here to read more
